Clinical trials
Overweight trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 8 |
| 2018 | 10 |
| 2019 | 10 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 20 |
| 2024 | 9 |
| 2025 | 22 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 72 |
| Recruiting | 33 |
| Active, not recruiting | 16 |
| Unknown status | 15 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 13 |
| Eli Lilly and Company | 12 |
| AstraZeneca | 7 |
| Loughborough University | 5 |
| University of Oxford | 5 |
| Amgen | 4 |
| Imperial College London | 4 |
| University of Glasgow | 4 |
| University of Leeds | 4 |
| University of Nottingham | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 144 |
| Obesity | 129 |
| Diabetes Mellitus, Type 2 | 16 |
| Weight Loss | 8 |
| Body Weight | 7 |
| Diabetes Mellitus | 6 |
| Metabolic Syndrome | 6 |
| Cardiovascular Diseases | 5 |
| Nutrition Disorders | 4 |
| Prediabetic State | 4 |
Trials
Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.